Results 1 to 5 of 5

EPA Issues New Guidance on Limiting Exposure to PFAS in Drinking Water

USA - June 16 2022 The U.S. Environmental Protection Agency (EPA) announced today new interim lifetime drinking water health advisories for perfluorooctanoic acid…

Daniel Goldberg-Gradess, Douglas E. Fleming III, Rachel Passaretti-Wu, Nathan Williams

FDA Requires “Patient-Decision Checklists” for Breast Implants: What Could This Mean for Industry?

USA - November 22 2021 The FDA announced on October 27, 2021, that it will restrict the sale of breast implants to healthcare providers and facilities that use a…

Jonathan S. Tam, Katherine Unger Davis, Justin M. Kadoura, Sharon Turret

New York’s Green Amendment: How Guidance from Other States Can Shape the Development of New York’s Newest Constitutional Right

USA - November 11 2021 Likened by some to motherhood and apple pie, the Environmental Rights Amendment was adopted by New York with a resounding “Yes” on November 2, 2021…

Allie Ozurovich, Sheila L Birnbaum, Mark S Cheffo, Rachel Passaretti-Wu, Lincoln Wilson

Litigation Risks in FDA Remote Interactive Evaluations

USA - November 1 2021 In March 2020, as the COVID-19 pandemic unfolded across the United States and around the world, FDA paused most foreign and domestic inspections in…

Julia Markham Cameron, Jonathan S. Tam, Emily Van Tuyl

PFAS: Expected Litigation Trends

USA - April 5 2021 The PFAS litigation landscape - already involving PFAS manufacturers and purchasers of P…

Sheila L Birnbaum, Mark S Cheffo, Michael A. Fazio, Douglas E. Fleming III, Rachel Passaretti-Wu, Nathan Williams